Beyond Air Inc (NAS:XAIR)
$ 0.445 -0.0351 (-7.31%) Market Cap: 32.13 Mil Enterprise Value: 30.98 Mil PE Ratio: 0 PB Ratio: 1.27 GF Score: 25/100

Beyond Air Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 15, 2023 / 01:20PM GMT
Release Date Price: $6.48 (-4.57%)
Suraj Kalia
Oppenheimer & Co. Inc. - Analyst

Good morning, everyone. Suraj Kalia, Senior Medical Device Analyst at Oppenheimer. The third day of the Oppenheimer Annual Healthcare Conference. We're pleased to have Beyond Air present this morning. From Beyond Air, we have Steve Lisi, CEO. Steve, I'll let you take the floor. I'll resurface about three to five minutes toward the end for Q&A.

Steve Lisi
Beyond Air, Inc. - CEO & Chairman on the Board

Great. Thanks, Suraj. Thanks for having us, much appreciated. So I'm going to talk about Beyond Air, the company. Here's our disclaimers. You can read them at your leisure.

Again, back to our mission of nitric oxide. Today, nitric oxide is approved and used in the hospital setting, restricted to the ICU only. We'll be taking it to all corners of the hospital and eventually into the patient's homes where they can self-administer nitric oxide.

These are our systems. So you can see in the middle here, we have our LungFit PH, which is FDA approved. This is FDA approved for persistent

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot